CStone Pharmaceuticals Company

CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide.
Technology: Biologics
Industry: Genomic and Epigenominc Instabillity
Headquarters: China
Founded Date: 2015
Employees Number: 101-250
Funding Status: IPO
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership